MiR-361-5p decreases the tumorigenicity of epithelial ovarian cancer cells by targeting at RPL22L1 and c-Met signaling. [electronic resource]
Publication details: International journal of clinical and experimental pathology 2018Description: 2588-2596 p. digitalISSN:- 1936-2625
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.